Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience.
Saved in:
| Title: | Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience. |
|---|---|
| Authors: | Elghawy O; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA., Wang J; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA., Leung OJ; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA., Swami N; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA., Carvajal V; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA., Yang G; Division of Precision and Computational Diagnostics, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Svoboda J; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Nasta SD; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Chong EA; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Schuster SJ; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Thomas CJ; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Carter JS; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bagg A; Department of Pathology and Laboratory Medicine, Division of Hematopathology, Hospital of the University of Pennsylvania, Philadelphia, PA., Barta SK; Division of Hematology Oncology, University of Pennsylvania, Philadelphia, PA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. Electronic address: Stefan.Barta@pennmedicine.upenn.edu. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2025 Jul; Vol. 25 (7), pp. 505-511.e2. Date of Electronic Publication: 2025 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2152-2669 |
|---|---|
| DOI: | 10.1016/j.clml.2025.01.017 |
